EP Patent

EP1870405A1 — Carbonylated (Aza)cyclohexanes as dopamine D3 receptor ligands

Assigned to Bioprojet SC · Expires 2007-12-26 · 18y expired

What this patent protects

The invention relates to compounds of the general formula (I): to the process for preparing them, and to the use thereof as a therapeutic agent.

USPTO Abstract

The invention relates to compounds of the general formula (I): to the process for preparing them, and to the use thereof as a therapeutic agent.

Drugs covered by this patent

cariprazine-hydrochloride (CARIPRAZINE HYDROCHLORIDE)

Patent Metadata

Patent number: EP1870405A1
Jurisdiction: EP
Classification: —
Expires: 2007-12-26
Drug substance claim: No
Drug product claim: No
Assignee: Bioprojet SC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.